ClearPoint Neuro, Inc. (CLPT) is a Medical - Devices company in the Healthcare sector, currently trading at $10.38. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is CLPT = $18 (+73.4% upside).
Valuation: CLPT trades at a trailing Price-to-Earnings (P/E) of -9.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.62.
Financials: revenue is $37M, +21.8%/yr average growth. Net income is $26M (loss), growing at -18.1%/yr. Net profit margin is -69.1% (negative). Gross margin is 61.4% (-4.4 pp trend).
Balance sheet: total debt is $58M against $28M equity (Debt-to-Equity (D/E) ratio 2.08, leveraged). Current ratio is 5.91 (strong liquidity). Debt-to-assets is 59.6%. Total assets: $98M.
Analyst outlook: 3 / 3 analysts rate CLPT as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 91/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 41/100 (Fail), Future 100/100 (Pass), Income 10/100 (Fail).
